Because of its dosing and subcutaneous delivery, HAEGARDA helps your working C1-INH levels stay high enough between doses to reduce the risk of an HAE attack from happening in the first place.
HAE attacks can occur when your levels of working C1-INH are too low
HAEGARDA adds working C1-INH to your body
HAEGARDA brings your working C1-INH levels back up and closer to normal, reducing your risk of an HAE attack
In clinical studies, the most common side effects reported with HAEGARDA were injection-site reactions (pain, redness, swelling), hypersensitivity (itching and rash), dizziness, and nasal symptoms, including stuffy or runny nose and sneezing. These are not the only side effects possible with HAEGARDA.